Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Cannabinoid Receptor-XL-001
XL-001

Chemical Structure : XL-001

CAS No.: 1426153-46-9

XL-001 (XL001)

Catalog No.: PC-35625Not For Human Use, Lab Use Only.

XL-001 (XL001) is a novel specific CB2 inverse agonist with Ki of 0.5 nM.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    XL-001 (XL001) is a novel specific CB2 inverse agonist with Ki of 0.5 nM.
    XL-001 inhibits in a dose-dependent fashion the fibrogenic response induced by CB2 overexpression, CB2 agonist or transforming growth factor-β1.
    XL-001 ameliorates kidney injury, fibrosis and inflammation in both the obstruction and ischemia/reperfusion models.

    Physicochemical Properties

    M.Wt 438.586
    Formula C25H30N2O3S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    N-(4-(diethylamino)benzyl)-4-methoxy-N-(p-tolyl)benzenesulfonamide

    References

    1. Zhou L, et al. Kidney Int. 2018 Aug 6. pii: S0085-2538(18)30397-1.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: